LivaNova PLC

LIVN · Moat type: UNBESTIMMT

MoatScore

5/10

Fair Value

50 USD

Margin of Safety

-64.8 %

Rating

BEOBACHTEN

LivaNova PLC develops and markets neuromodulative and cardiovascular medical devices, in particular vagus nerve stimulators for the treatment of epilepsy and depression as well as heart-lung machines for cardiac surgery, and generates recurring revenue from devices and consumables.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.